LTD Health House

Tbilisi 0144

0 studies enrolling now · 4 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, Dedifferentiated Liposarcoma, Early Breast Cancer

Studies at this site

• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• A Study of Lerociclib in Participants With Advanced Breast Cancer — Stopped early
• Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma — Stopped early
• Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer — Completed